nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—CYP3A4—Thiotepa—sarcoma	0.0591	0.156	CbGbCtD
Boceprevir—ABCB1—Dactinomycin—sarcoma	0.0474	0.125	CbGbCtD
Boceprevir—CYP3A5—Vincristine—sarcoma	0.0448	0.118	CbGbCtD
Boceprevir—ABCB1—Mitoxantrone—sarcoma	0.0424	0.112	CbGbCtD
Boceprevir—CYP3A5—Etoposide—sarcoma	0.0411	0.108	CbGbCtD
Boceprevir—ABCB1—Vincristine—sarcoma	0.0292	0.077	CbGbCtD
Boceprevir—ABCB1—Etoposide—sarcoma	0.0267	0.0706	CbGbCtD
Boceprevir—CYP3A4—Mitoxantrone—sarcoma	0.0254	0.0671	CbGbCtD
Boceprevir—ABCB1—Doxorubicin—sarcoma	0.0182	0.0482	CbGbCtD
Boceprevir—CYP3A4—Vincristine—sarcoma	0.0175	0.0462	CbGbCtD
Boceprevir—CYP3A4—Etoposide—sarcoma	0.016	0.0423	CbGbCtD
Boceprevir—CTSK—periosteum—sarcoma	0.0127	0.0625	CbGeAlD
Boceprevir—CYP3A4—Doxorubicin—sarcoma	0.0109	0.0288	CbGbCtD
Boceprevir—CTSK—skull—sarcoma	0.0104	0.0514	CbGeAlD
Boceprevir—CTSK—leg—sarcoma	0.0101	0.0498	CbGeAlD
Boceprevir—CTSK—forelimb—sarcoma	0.0101	0.0495	CbGeAlD
Boceprevir—CTSK—hindlimb—sarcoma	0.00904	0.0445	CbGeAlD
Boceprevir—CTSK—cartilage tissue—sarcoma	0.0089	0.0438	CbGeAlD
Boceprevir—CTSK—appendage—sarcoma	0.00776	0.0382	CbGeAlD
Boceprevir—CTSV—myometrium—sarcoma	0.00435	0.0214	CbGeAlD
Boceprevir—CTSV—seminal vesicle—sarcoma	0.00393	0.0193	CbGeAlD
Boceprevir—CTSK—mammary gland—sarcoma	0.00377	0.0186	CbGeAlD
Boceprevir—CTSV—hematopoietic system—sarcoma	0.00374	0.0184	CbGeAlD
Boceprevir—CMA1—hematopoietic system—sarcoma	0.00357	0.0176	CbGeAlD
Boceprevir—CTSL—myometrium—sarcoma	0.00355	0.0175	CbGeAlD
Boceprevir—CMA1—connective tissue—sarcoma	0.00344	0.0169	CbGeAlD
Boceprevir—CTSL—embryo—sarcoma	0.00342	0.0168	CbGeAlD
Boceprevir—CTSV—skin of body—sarcoma	0.00325	0.016	CbGeAlD
Boceprevir—CTSL—seminal vesicle—sarcoma	0.00321	0.0158	CbGeAlD
Boceprevir—CMA1—smooth muscle tissue—sarcoma	0.00314	0.0155	CbGeAlD
Boceprevir—CMA1—skin of body—sarcoma	0.0031	0.0153	CbGeAlD
Boceprevir—CTSL—hematopoietic system—sarcoma	0.00305	0.015	CbGeAlD
Boceprevir—CTSL—connective tissue—sarcoma	0.00294	0.0145	CbGeAlD
Boceprevir—CTSL—smooth muscle tissue—sarcoma	0.00269	0.0132	CbGeAlD
Boceprevir—CTSK—myometrium—sarcoma	0.00268	0.0132	CbGeAlD
Boceprevir—CTSL—skin of body—sarcoma	0.00265	0.0131	CbGeAlD
Boceprevir—CTSV—lymphoid tissue—sarcoma	0.00263	0.0129	CbGeAlD
Boceprevir—CMA1—lymphoid tissue—sarcoma	0.00251	0.0124	CbGeAlD
Boceprevir—CTSK—seminal vesicle—sarcoma	0.00242	0.0119	CbGeAlD
Boceprevir—CTSS—myometrium—sarcoma	0.00235	0.0115	CbGeAlD
Boceprevir—CTSL—cardiac atrium—sarcoma	0.00232	0.0114	CbGeAlD
Boceprevir—CTSL—uterus—sarcoma	0.00231	0.0113	CbGeAlD
Boceprevir—CTSK—hematopoietic system—sarcoma	0.0023	0.0113	CbGeAlD
Boceprevir—CMA1—bone marrow—sarcoma	0.00229	0.0113	CbGeAlD
Boceprevir—CTSS—embryo—sarcoma	0.00226	0.0111	CbGeAlD
Boceprevir—CTSK—connective tissue—sarcoma	0.00221	0.0109	CbGeAlD
Boceprevir—CTSL—lymphoid tissue—sarcoma	0.00215	0.0106	CbGeAlD
Boceprevir—CTSS—seminal vesicle—sarcoma	0.00212	0.0104	CbGeAlD
Boceprevir—CTSV—testis—sarcoma	0.00205	0.0101	CbGeAlD
Boceprevir—CTSK—smooth muscle tissue—sarcoma	0.00203	0.00997	CbGeAlD
Boceprevir—CTSL—tendon—sarcoma	0.00202	0.00994	CbGeAlD
Boceprevir—CTSS—hematopoietic system—sarcoma	0.00202	0.00992	CbGeAlD
Boceprevir—CTSK—skin of body—sarcoma	0.002	0.00984	CbGeAlD
Boceprevir—CTSL—bone marrow—sarcoma	0.00196	0.00963	CbGeAlD
Boceprevir—CTSS—connective tissue—sarcoma	0.00194	0.00955	CbGeAlD
Boceprevir—CMA1—liver—sarcoma	0.00185	0.0091	CbGeAlD
Boceprevir—CTSS—smooth muscle tissue—sarcoma	0.00177	0.00873	CbGeAlD
Boceprevir—CTSS—skin of body—sarcoma	0.00175	0.00862	CbGeAlD
Boceprevir—CTSK—cardiac atrium—sarcoma	0.00175	0.00859	CbGeAlD
Boceprevir—CTSK—uterus—sarcoma	0.00174	0.00855	CbGeAlD
Boceprevir—CTSL—testis—sarcoma	0.00167	0.00823	CbGeAlD
Boceprevir—CTSK—lymphoid tissue—sarcoma	0.00162	0.00797	CbGeAlD
Boceprevir—CTSL—liver—sarcoma	0.00158	0.00778	CbGeAlD
Boceprevir—CTSS—uterus—sarcoma	0.00152	0.00749	CbGeAlD
Boceprevir—CTSK—tendon—sarcoma	0.00152	0.00749	CbGeAlD
Boceprevir—CTSK—bone marrow—sarcoma	0.00147	0.00725	CbGeAlD
Boceprevir—CTSS—lymphoid tissue—sarcoma	0.00142	0.00698	CbGeAlD
Boceprevir—CMA1—lymph node—sarcoma	0.00142	0.00698	CbGeAlD
Boceprevir—CTSS—tendon—sarcoma	0.00133	0.00656	CbGeAlD
Boceprevir—CTSS—bone marrow—sarcoma	0.00129	0.00636	CbGeAlD
Boceprevir—CTSK—testis—sarcoma	0.00126	0.0062	CbGeAlD
Boceprevir—CTSL—lymph node—sarcoma	0.00121	0.00597	CbGeAlD
Boceprevir—CTSK—liver—sarcoma	0.00119	0.00586	CbGeAlD
Boceprevir—CTSS—testis—sarcoma	0.0011	0.00543	CbGeAlD
Boceprevir—CTSS—liver—sarcoma	0.00104	0.00514	CbGeAlD
Boceprevir—CTSK—lymph node—sarcoma	0.000914	0.0045	CbGeAlD
Boceprevir—CTSS—lymph node—sarcoma	0.0008	0.00394	CbGeAlD
Boceprevir—CYP3A5—hematopoietic system—sarcoma	0.000669	0.00329	CbGeAlD
Boceprevir—CYP3A4—hematopoietic system—sarcoma	0.000502	0.00247	CbGeAlD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—NPM1—sarcoma	0.000417	0.00229	CbGpPWpGaD
Boceprevir—ABCB1—myometrium—sarcoma	0.000414	0.00204	CbGeAlD
Boceprevir—CMA1—Signaling by SCF-KIT—EGFR—sarcoma	0.000401	0.0022	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—MMP2—sarcoma	0.0004	0.0022	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—PLCG1—sarcoma	0.000398	0.00219	CbGpPWpGaD
Boceprevir—ABCB1—embryo—sarcoma	0.000398	0.00196	CbGeAlD
Boceprevir—CTSL—Immune System—CD34—sarcoma	0.000396	0.00217	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD34—sarcoma	0.000396	0.00217	CbGpPWpGaD
Boceprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—sarcoma	0.000396	0.00217	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—PTPRC—sarcoma	0.000391	0.00215	CbGpPWpGaD
Boceprevir—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000388	0.00213	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—PLCG1—sarcoma	0.000382	0.0021	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—KRAS—sarcoma	0.000379	0.00208	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—ATF1—sarcoma	0.000378	0.00208	CbGpPWpGaD
Boceprevir—CTSS—Toll-Like Receptors Cascades—JUN—sarcoma	0.000375	0.00206	CbGpPWpGaD
Boceprevir—ABCB1—seminal vesicle—sarcoma	0.000374	0.00184	CbGeAlD
Boceprevir—CTSS—Extracellular matrix organization—KDR—sarcoma	0.00036	0.00198	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—MMP2—sarcoma	0.000357	0.00196	CbGpPWpGaD
Boceprevir—ABCB1—hematopoietic system—sarcoma	0.000356	0.00175	CbGeAlD
Boceprevir—CYP3A5—liver—sarcoma	0.000347	0.00171	CbGeAlD
Boceprevir—CTSL—Innate Immune System—FOXO1—sarcoma	0.000341	0.00187	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—FOXO1—sarcoma	0.000341	0.00187	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—PDGFRB—sarcoma	0.00034	0.00187	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—PDGFRB—sarcoma	0.00034	0.00187	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—PDGFRA—sarcoma	0.000335	0.00184	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—PDGFRA—sarcoma	0.000335	0.00184	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—PLCG1—sarcoma	0.000328	0.0018	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CD34—sarcoma	0.000328	0.0018	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—FOXO1—sarcoma	0.000328	0.0018	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—FOXO1—sarcoma	0.000328	0.0018	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—PDGFRB—sarcoma	0.000327	0.0018	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—PDGFRB—sarcoma	0.000327	0.0018	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—HRAS—sarcoma	0.000322	0.00177	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—PDGFRA—sarcoma	0.000322	0.00177	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—PDGFRA—sarcoma	0.000322	0.00177	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—PTPRC—sarcoma	0.000322	0.00177	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—PLCG1—sarcoma	0.000315	0.00173	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—ATF1—sarcoma	0.000312	0.00171	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—CXCR4—sarcoma	0.000294	0.00162	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—MMP2—sarcoma	0.000294	0.00161	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PTPRC—sarcoma	0.000286	0.00157	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PTPRC—sarcoma	0.000286	0.00157	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—FOXO1—sarcoma	0.000283	0.00155	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—PDGFRB—sarcoma	0.000282	0.00155	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PLCG1—sarcoma	0.00028	0.00154	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PLCG1—sarcoma	0.00028	0.00154	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—PDGFRA—sarcoma	0.000278	0.00153	CbGpPWpGaD
Boceprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—sarcoma	0.000275	0.00151	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—FOXO1—sarcoma	0.000271	0.00149	CbGpPWpGaD
Boceprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—sarcoma	0.000271	0.00149	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—PDGFRB—sarcoma	0.000271	0.00149	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CD34—sarcoma	0.00027	0.00148	CbGpPWpGaD
Boceprevir—ABCB1—uterus—sarcoma	0.000269	0.00132	CbGeAlD
Boceprevir—CTSK—Adaptive Immune System—PDGFRA—sarcoma	0.000267	0.00146	CbGpPWpGaD
Boceprevir—CTSL—Immune System—ATF1—sarcoma	0.000266	0.00146	CbGpPWpGaD
Boceprevir—CTSV—Immune System—ATF1—sarcoma	0.000266	0.00146	CbGpPWpGaD
Boceprevir—CYP3A4—liver—sarcoma	0.00026	0.00128	CbGeAlD
Boceprevir—CTSL—Innate Immune System—KIT—sarcoma	0.00026	0.00143	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—KIT—sarcoma	0.00026	0.00143	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TLE1—sarcoma	0.000254	0.00139	CbGpPWpGaD
Boceprevir—ABCB1—lymphoid tissue—sarcoma	0.00025	0.00123	CbGeAlD
Boceprevir—CTSL—Adaptive Immune System—KIT—sarcoma	0.00025	0.00137	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—KIT—sarcoma	0.00025	0.00137	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CREB1—sarcoma	0.000247	0.00136	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—CREB1—sarcoma	0.000247	0.00136	CbGpPWpGaD
Boceprevir—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000239	0.00131	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CREB1—sarcoma	0.000238	0.0013	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CREB1—sarcoma	0.000238	0.0013	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PTPRC—sarcoma	0.000237	0.0013	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—FOXO1—sarcoma	0.000233	0.00128	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—PDGFRB—sarcoma	0.000232	0.00128	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PLCG1—sarcoma	0.000232	0.00127	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—PDGFRA—sarcoma	0.000229	0.00126	CbGpPWpGaD
Boceprevir—ABCB1—bone marrow—sarcoma	0.000228	0.00112	CbGeAlD
Boceprevir—CTSS—Adaptive Immune System—FOXO1—sarcoma	0.000223	0.00123	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—PDGFRB—sarcoma	0.000223	0.00123	CbGpPWpGaD
Boceprevir—CTSK—Immune System—ATF1—sarcoma	0.00022	0.00121	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—PDGFRA—sarcoma	0.00022	0.00121	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—KIT—sarcoma	0.000215	0.00118	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—VEGFC—sarcoma	0.000214	0.00118	CbGpPWpGaD
Boceprevir—Muscular weakness—Doxorubicin—sarcoma	0.000213	0.000903	CcSEcCtD
Boceprevir—Dysuria—Epirubicin—sarcoma	0.000211	0.000894	CcSEcCtD
Boceprevir—Neutropenia—Epirubicin—sarcoma	0.000211	0.000894	CcSEcCtD
Boceprevir—Dizziness—Thiotepa—sarcoma	0.000211	0.000893	CcSEcCtD
Boceprevir—Abdominal distension—Doxorubicin—sarcoma	0.00021	0.000891	CcSEcCtD
Boceprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—sarcoma	0.00021	0.00115	CbGpPWpGaD
Boceprevir—Influenza—Doxorubicin—sarcoma	0.000209	0.000885	CcSEcCtD
Boceprevir—Dysphagia—Doxorubicin—sarcoma	0.000209	0.000885	CcSEcCtD
Boceprevir—Pollakiuria—Epirubicin—sarcoma	0.000209	0.000883	CcSEcCtD
Boceprevir—Hypersensitivity—Vincristine—sarcoma	0.000208	0.000882	CcSEcCtD
Boceprevir—Eosinophilia—Doxorubicin—sarcoma	0.000207	0.000876	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—KIT—sarcoma	0.000207	0.00114	CbGpPWpGaD
Boceprevir—Photosensitivity reaction—Epirubicin—sarcoma	0.000206	0.000873	CcSEcCtD
Boceprevir—Paraesthesia—Etoposide—sarcoma	0.000206	0.000871	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—CREB1—sarcoma	0.000205	0.00113	CbGpPWpGaD
Boceprevir—Pancreatitis—Doxorubicin—sarcoma	0.000205	0.000868	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—MDM2—sarcoma	0.000205	0.00112	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—MDM2—sarcoma	0.000205	0.00112	CbGpPWpGaD
Boceprevir—Weight decreased—Epirubicin—sarcoma	0.000204	0.000865	CcSEcCtD
Boceprevir—Dyspnoea—Etoposide—sarcoma	0.000204	0.000865	CcSEcCtD
Boceprevir—Hyperglycaemia—Epirubicin—sarcoma	0.000204	0.000863	CcSEcCtD
Boceprevir—Hypersensitivity—Mitoxantrone—sarcoma	0.000203	0.000859	CcSEcCtD
Boceprevir—Asthenia—Vincristine—sarcoma	0.000203	0.000859	CcSEcCtD
Boceprevir—Vomiting—Thiotepa—sarcoma	0.000203	0.000859	CcSEcCtD
Boceprevir—Pneumonia—Epirubicin—sarcoma	0.000203	0.000858	CcSEcCtD
Boceprevir—Infestation NOS—Epirubicin—sarcoma	0.000201	0.000853	CcSEcCtD
Boceprevir—Infestation—Epirubicin—sarcoma	0.000201	0.000853	CcSEcCtD
Boceprevir—Vomiting—Dactinomycin—sarcoma	0.000201	0.000852	CcSEcCtD
Boceprevir—Rash—Thiotepa—sarcoma	0.000201	0.000852	CcSEcCtD
Boceprevir—Bronchitis—Doxorubicin—sarcoma	0.000201	0.000851	CcSEcCtD
Boceprevir—Dermatitis—Thiotepa—sarcoma	0.000201	0.000851	CcSEcCtD
Boceprevir—Headache—Thiotepa—sarcoma	0.0002	0.000846	CcSEcCtD
Boceprevir—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.0002	0.000845	CcSEcCtD
Boceprevir—Rash—Dactinomycin—sarcoma	0.0002	0.000845	CcSEcCtD
Boceprevir—Decreased appetite—Etoposide—sarcoma	0.000199	0.000843	CcSEcCtD
Boceprevir—CTSV—Immune System—FOXO1—sarcoma	0.000199	0.00109	CbGpPWpGaD
Boceprevir—CTSL—Immune System—FOXO1—sarcoma	0.000199	0.00109	CbGpPWpGaD
Boceprevir—Pancytopenia—Doxorubicin—sarcoma	0.000198	0.00084	CcSEcCtD
Boceprevir—CTSL—Immune System—PDGFRB—sarcoma	0.000198	0.00109	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PDGFRB—sarcoma	0.000198	0.00109	CbGpPWpGaD
Boceprevir—Gastrointestinal disorder—Etoposide—sarcoma	0.000198	0.000838	CcSEcCtD
Boceprevir—Asthenia—Mitoxantrone—sarcoma	0.000198	0.000837	CcSEcCtD
Boceprevir—Fatigue—Etoposide—sarcoma	0.000198	0.000836	CcSEcCtD
Boceprevir—Neuropathy peripheral—Epirubicin—sarcoma	0.000197	0.000836	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—CREB1—sarcoma	0.000197	0.00108	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—MDM2—sarcoma	0.000197	0.00108	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—MDM2—sarcoma	0.000197	0.00108	CbGpPWpGaD
Boceprevir—Stomatitis—Epirubicin—sarcoma	0.000196	0.000831	CcSEcCtD
Boceprevir—Pain—Etoposide—sarcoma	0.000196	0.00083	CcSEcCtD
Boceprevir—Constipation—Etoposide—sarcoma	0.000196	0.00083	CcSEcCtD
Boceprevir—Urinary tract infection—Epirubicin—sarcoma	0.000196	0.000829	CcSEcCtD
Boceprevir—Conjunctivitis—Epirubicin—sarcoma	0.000196	0.000829	CcSEcCtD
Boceprevir—Dysuria—Doxorubicin—sarcoma	0.000195	0.000827	CcSEcCtD
Boceprevir—Neutropenia—Doxorubicin—sarcoma	0.000195	0.000827	CcSEcCtD
Boceprevir—CTSV—Immune System—PDGFRA—sarcoma	0.000195	0.00107	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PTPRC—sarcoma	0.000195	0.00107	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PDGFRA—sarcoma	0.000195	0.00107	CbGpPWpGaD
Boceprevir—ABCB1—testis—sarcoma	0.000195	0.000959	CbGeAlD
Boceprevir—Diarrhoea—Vincristine—sarcoma	0.000194	0.000819	CcSEcCtD
Boceprevir—Pollakiuria—Doxorubicin—sarcoma	0.000193	0.000817	CcSEcCtD
Boceprevir—CTSS—Immune System—PLCG1—sarcoma	0.000191	0.00105	CbGpPWpGaD
Boceprevir—Photosensitivity reaction—Doxorubicin—sarcoma	0.000191	0.000808	CcSEcCtD
Boceprevir—Hepatobiliary disease—Epirubicin—sarcoma	0.00019	0.000806	CcSEcCtD
Boceprevir—Epistaxis—Epirubicin—sarcoma	0.00019	0.000804	CcSEcCtD
Boceprevir—Nausea—Thiotepa—sarcoma	0.000189	0.000802	CcSEcCtD
Boceprevir—Weight decreased—Doxorubicin—sarcoma	0.000189	0.000801	CcSEcCtD
Boceprevir—Sinusitis—Epirubicin—sarcoma	0.000189	0.0008	CcSEcCtD
Boceprevir—Feeling abnormal—Etoposide—sarcoma	0.000189	0.0008	CcSEcCtD
Boceprevir—Hyperglycaemia—Doxorubicin—sarcoma	0.000189	0.000798	CcSEcCtD
Boceprevir—Diarrhoea—Mitoxantrone—sarcoma	0.000188	0.000798	CcSEcCtD
Boceprevir—Nausea—Dactinomycin—sarcoma	0.000188	0.000796	CcSEcCtD
Boceprevir—Agranulocytosis—Epirubicin—sarcoma	0.000188	0.000796	CcSEcCtD
Boceprevir—Pneumonia—Doxorubicin—sarcoma	0.000187	0.000794	CcSEcCtD
Boceprevir—Gastrointestinal pain—Etoposide—sarcoma	0.000187	0.000793	CcSEcCtD
Boceprevir—CMA1—Metabolism of proteins—MMP2—sarcoma	0.000187	0.00103	CbGpPWpGaD
Boceprevir—Dizziness—Vincristine—sarcoma	0.000187	0.000792	CcSEcCtD
Boceprevir—Infestation—Doxorubicin—sarcoma	0.000186	0.000789	CcSEcCtD
Boceprevir—Infestation NOS—Doxorubicin—sarcoma	0.000186	0.000789	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—PDGFRA—sarcoma	0.000185	0.00102	CbGpPWpGaD
Boceprevir—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000185	0.000782	CcSEcCtD
Boceprevir—ABCB1—liver—sarcoma	0.000184	0.000906	CbGeAlD
Boceprevir—Neuropathy peripheral—Doxorubicin—sarcoma	0.000183	0.000773	CcSEcCtD
Boceprevir—Urticaria—Etoposide—sarcoma	0.000182	0.000771	CcSEcCtD
Boceprevir—Stomatitis—Doxorubicin—sarcoma	0.000182	0.000769	CcSEcCtD
Boceprevir—CTSS—Immune System—ATF1—sarcoma	0.000181	0.000997	CbGpPWpGaD
Boceprevir—Rhinitis—Epirubicin—sarcoma	0.000181	0.000767	CcSEcCtD
Boceprevir—Body temperature increased—Etoposide—sarcoma	0.000181	0.000767	CcSEcCtD
Boceprevir—Abdominal pain—Etoposide—sarcoma	0.000181	0.000767	CcSEcCtD
Boceprevir—Conjunctivitis—Doxorubicin—sarcoma	0.000181	0.000767	CcSEcCtD
Boceprevir—Urinary tract infection—Doxorubicin—sarcoma	0.000181	0.000767	CcSEcCtD
Boceprevir—Hypoaesthesia—Epirubicin—sarcoma	0.00018	0.000762	CcSEcCtD
Boceprevir—Vomiting—Vincristine—sarcoma	0.00018	0.000762	CcSEcCtD
Boceprevir—Pharyngitis—Epirubicin—sarcoma	0.000179	0.00076	CcSEcCtD
Boceprevir—Urinary tract disorder—Epirubicin—sarcoma	0.000179	0.000756	CcSEcCtD
Boceprevir—Rash—Vincristine—sarcoma	0.000178	0.000755	CcSEcCtD
Boceprevir—Dermatitis—Vincristine—sarcoma	0.000178	0.000754	CcSEcCtD
Boceprevir—Oedema peripheral—Epirubicin—sarcoma	0.000178	0.000754	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—JUN—sarcoma	0.000178	0.000977	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—JUN—sarcoma	0.000178	0.000977	CbGpPWpGaD
Boceprevir—Connective tissue disorder—Epirubicin—sarcoma	0.000178	0.000752	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—KIT—sarcoma	0.000177	0.000974	CbGpPWpGaD
Boceprevir—Urethral disorder—Epirubicin—sarcoma	0.000177	0.00075	CcSEcCtD
Boceprevir—Headache—Vincristine—sarcoma	0.000177	0.00075	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—CTNNB1—sarcoma	0.000177	0.00097	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CTNNB1—sarcoma	0.000177	0.00097	CbGpPWpGaD
Boceprevir—Hepatobiliary disease—Doxorubicin—sarcoma	0.000176	0.000746	CcSEcCtD
Boceprevir—Epistaxis—Doxorubicin—sarcoma	0.000176	0.000744	CcSEcCtD
Boceprevir—Vomiting—Mitoxantrone—sarcoma	0.000175	0.000742	CcSEcCtD
Boceprevir—Sinusitis—Doxorubicin—sarcoma	0.000175	0.00074	CcSEcCtD
Boceprevir—Visual impairment—Epirubicin—sarcoma	0.000174	0.000738	CcSEcCtD
Boceprevir—Agranulocytosis—Doxorubicin—sarcoma	0.000174	0.000736	CcSEcCtD
Boceprevir—Rash—Mitoxantrone—sarcoma	0.000174	0.000735	CcSEcCtD
Boceprevir—Dermatitis—Mitoxantrone—sarcoma	0.000174	0.000735	CcSEcCtD
Boceprevir—Headache—Mitoxantrone—sarcoma	0.000173	0.000731	CcSEcCtD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	0.000172	0.000945	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—FLT1—sarcoma	0.000171	0.00094	CbGpPWpGaD
Boceprevir—Erythema multiforme—Epirubicin—sarcoma	0.000171	0.000724	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—KIT—sarcoma	0.00017	0.000935	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—MDM2—sarcoma	0.00017	0.000931	CbGpPWpGaD
Boceprevir—Eye disorder—Epirubicin—sarcoma	0.000169	0.000715	CcSEcCtD
Boceprevir—Hypersensitivity—Etoposide—sarcoma	0.000169	0.000715	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—CREB1—sarcoma	0.000169	0.000927	CbGpPWpGaD
Boceprevir—Tinnitus—Epirubicin—sarcoma	0.000169	0.000714	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—PLCG1—sarcoma	0.000168	0.000924	CbGpPWpGaD
Boceprevir—Nausea—Vincristine—sarcoma	0.000168	0.000711	CcSEcCtD
Boceprevir—Cardiac disorder—Epirubicin—sarcoma	0.000168	0.00071	CcSEcCtD
Boceprevir—Flushing—Epirubicin—sarcoma	0.000168	0.00071	CcSEcCtD
Boceprevir—Rhinitis—Doxorubicin—sarcoma	0.000168	0.00071	CcSEcCtD
Boceprevir—Hypoaesthesia—Doxorubicin—sarcoma	0.000166	0.000705	CcSEcCtD
Boceprevir—Pharyngitis—Doxorubicin—sarcoma	0.000166	0.000703	CcSEcCtD
Boceprevir—Urinary tract disorder—Doxorubicin—sarcoma	0.000165	0.0007	CcSEcCtD
Boceprevir—Oedema peripheral—Doxorubicin—sarcoma	0.000165	0.000698	CcSEcCtD
Boceprevir—CTSK—Immune System—FOXO1—sarcoma	0.000165	0.000904	CbGpPWpGaD
Boceprevir—Asthenia—Etoposide—sarcoma	0.000164	0.000696	CcSEcCtD
Boceprevir—Connective tissue disorder—Doxorubicin—sarcoma	0.000164	0.000696	CcSEcCtD
Boceprevir—CTSK—Immune System—PDGFRB—sarcoma	0.000164	0.000902	CbGpPWpGaD
Boceprevir—Angiopathy—Epirubicin—sarcoma	0.000164	0.000695	CcSEcCtD
Boceprevir—Urethral disorder—Doxorubicin—sarcoma	0.000164	0.000694	CcSEcCtD
Boceprevir—Nausea—Mitoxantrone—sarcoma	0.000164	0.000693	CcSEcCtD
Boceprevir—Immune system disorder—Epirubicin—sarcoma	0.000163	0.000691	CcSEcCtD
Boceprevir—Mediastinal disorder—Epirubicin—sarcoma	0.000163	0.00069	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—MDM2—sarcoma	0.000163	0.000894	CbGpPWpGaD
Boceprevir—Chills—Epirubicin—sarcoma	0.000162	0.000687	CcSEcCtD
Boceprevir—Pruritus—Etoposide—sarcoma	0.000162	0.000686	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—CREB1—sarcoma	0.000162	0.00089	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PDGFRA—sarcoma	0.000162	0.000888	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CXCR4—sarcoma	0.000162	0.000888	CbGpPWpGaD
Boceprevir—Arrhythmia—Epirubicin—sarcoma	0.000162	0.000684	CcSEcCtD
Boceprevir—Visual impairment—Doxorubicin—sarcoma	0.000161	0.000683	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—ATF1—sarcoma	0.00016	0.000878	CbGpPWpGaD
Boceprevir—Alopecia—Epirubicin—sarcoma	0.00016	0.000676	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—SRC—sarcoma	0.00016	0.000876	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—SRC—sarcoma	0.00016	0.000876	CbGpPWpGaD
Boceprevir—Mental disorder—Epirubicin—sarcoma	0.000158	0.000671	CcSEcCtD
Boceprevir—Erythema multiforme—Doxorubicin—sarcoma	0.000158	0.00067	CcSEcCtD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—CREB1—sarcoma	0.000158	0.000866	CbGpPWpGaD
Boceprevir—Malnutrition—Epirubicin—sarcoma	0.000157	0.000666	CcSEcCtD
Boceprevir—Erythema—Epirubicin—sarcoma	0.000157	0.000666	CcSEcCtD
Boceprevir—Diarrhoea—Etoposide—sarcoma	0.000157	0.000664	CcSEcCtD
Boceprevir—Eye disorder—Doxorubicin—sarcoma	0.000156	0.000662	CcSEcCtD
Boceprevir—Tinnitus—Doxorubicin—sarcoma	0.000156	0.00066	CcSEcCtD
Boceprevir—Flushing—Doxorubicin—sarcoma	0.000155	0.000657	CcSEcCtD
Boceprevir—Cardiac disorder—Doxorubicin—sarcoma	0.000155	0.000657	CcSEcCtD
Boceprevir—Flatulence—Epirubicin—sarcoma	0.000155	0.000657	CcSEcCtD
Boceprevir—Dysgeusia—Epirubicin—sarcoma	0.000154	0.000653	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—NRAS—sarcoma	0.000154	0.000843	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—NRAS—sarcoma	0.000154	0.000843	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—SRC—sarcoma	0.000153	0.000842	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—SRC—sarcoma	0.000153	0.000842	CbGpPWpGaD
Boceprevir—Back pain—Epirubicin—sarcoma	0.000152	0.000645	CcSEcCtD
Boceprevir—Angiopathy—Doxorubicin—sarcoma	0.000152	0.000643	CcSEcCtD
Boceprevir—Dizziness—Etoposide—sarcoma	0.000152	0.000642	CcSEcCtD
Boceprevir—CTSL—Immune System—KIT—sarcoma	0.000151	0.000831	CbGpPWpGaD
Boceprevir—CTSV—Immune System—KIT—sarcoma	0.000151	0.000831	CbGpPWpGaD
Boceprevir—Muscle spasms—Epirubicin—sarcoma	0.000151	0.000641	CcSEcCtD
Boceprevir—Immune system disorder—Doxorubicin—sarcoma	0.000151	0.00064	CcSEcCtD
Boceprevir—Mediastinal disorder—Doxorubicin—sarcoma	0.000151	0.000638	CcSEcCtD
Boceprevir—Chills—Doxorubicin—sarcoma	0.00015	0.000636	CcSEcCtD
Boceprevir—Arrhythmia—Doxorubicin—sarcoma	0.000149	0.000633	CcSEcCtD
Boceprevir—Vision blurred—Epirubicin—sarcoma	0.000148	0.000628	CcSEcCtD
Boceprevir—Alopecia—Doxorubicin—sarcoma	0.000148	0.000626	CcSEcCtD
Boceprevir—CTSL—Adaptive Immune System—NRAS—sarcoma	0.000147	0.00081	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—NRAS—sarcoma	0.000147	0.00081	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—JUN—sarcoma	0.000147	0.00081	CbGpPWpGaD
Boceprevir—Mental disorder—Doxorubicin—sarcoma	0.000147	0.000621	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—CTNNB1—sarcoma	0.000146	0.000803	CbGpPWpGaD
Boceprevir—Ill-defined disorder—Epirubicin—sarcoma	0.000146	0.000618	CcSEcCtD
Boceprevir—Vomiting—Etoposide—sarcoma	0.000146	0.000617	CcSEcCtD
Boceprevir—Erythema—Doxorubicin—sarcoma	0.000146	0.000617	CcSEcCtD
Boceprevir—Malnutrition—Doxorubicin—sarcoma	0.000146	0.000617	CcSEcCtD
Boceprevir—Anaemia—Epirubicin—sarcoma	0.000145	0.000616	CcSEcCtD
Boceprevir—Agitation—Epirubicin—sarcoma	0.000145	0.000612	CcSEcCtD
Boceprevir—Rash—Etoposide—sarcoma	0.000144	0.000612	CcSEcCtD
Boceprevir—Dermatitis—Etoposide—sarcoma	0.000144	0.000611	CcSEcCtD
Boceprevir—CTSV—Immune System—CREB1—sarcoma	0.000144	0.000791	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CREB1—sarcoma	0.000144	0.000791	CbGpPWpGaD
Boceprevir—Headache—Etoposide—sarcoma	0.000144	0.000608	CcSEcCtD
Boceprevir—Flatulence—Doxorubicin—sarcoma	0.000143	0.000608	CcSEcCtD
Boceprevir—CMA1—Metabolism of proteins—CTNNB1—sarcoma	0.000143	0.000788	CbGpPWpGaD
Boceprevir—Dysgeusia—Doxorubicin—sarcoma	0.000143	0.000604	CcSEcCtD
Boceprevir—Malaise—Epirubicin—sarcoma	0.000142	0.000601	CcSEcCtD
Boceprevir—Vertigo—Epirubicin—sarcoma	0.000141	0.000599	CcSEcCtD
Boceprevir—ABCB1—lymph node—sarcoma	0.000141	0.000695	CbGeAlD
Boceprevir—Syncope—Epirubicin—sarcoma	0.000141	0.000598	CcSEcCtD
Boceprevir—Leukopenia—Epirubicin—sarcoma	0.000141	0.000597	CcSEcCtD
Boceprevir—Back pain—Doxorubicin—sarcoma	0.000141	0.000596	CcSEcCtD
Boceprevir—Muscle spasms—Doxorubicin—sarcoma	0.00014	0.000593	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—EGFR—sarcoma	0.00014	0.000768	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—EGFR—sarcoma	0.00014	0.000768	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—MDM2—sarcoma	0.00014	0.000767	CbGpPWpGaD
Boceprevir—Palpitations—Epirubicin—sarcoma	0.000139	0.000589	CcSEcCtD
Boceprevir—Loss of consciousness—Epirubicin—sarcoma	0.000138	0.000586	CcSEcCtD
Boceprevir—Cough—Epirubicin—sarcoma	0.000137	0.000582	CcSEcCtD
Boceprevir—Vision blurred—Doxorubicin—sarcoma	0.000137	0.000581	CcSEcCtD
Boceprevir—Nausea—Etoposide—sarcoma	0.000136	0.000576	CcSEcCtD
Boceprevir—Hypertension—Epirubicin—sarcoma	0.000136	0.000575	CcSEcCtD
Boceprevir—CTSS—Immune System—FOXO1—sarcoma	0.000136	0.000744	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PDGFRB—sarcoma	0.000135	0.000743	CbGpPWpGaD
Boceprevir—Ill-defined disorder—Doxorubicin—sarcoma	0.000135	0.000572	CcSEcCtD
Boceprevir—Anaemia—Doxorubicin—sarcoma	0.000135	0.00057	CcSEcCtD
Boceprevir—CTSL—Adaptive Immune System—EGFR—sarcoma	0.000134	0.000738	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—EGFR—sarcoma	0.000134	0.000738	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—MDM2—sarcoma	0.000134	0.000737	CbGpPWpGaD
Boceprevir—Myalgia—Epirubicin—sarcoma	0.000134	0.000567	CcSEcCtD
Boceprevir—Arthralgia—Epirubicin—sarcoma	0.000134	0.000567	CcSEcCtD
Boceprevir—Chest pain—Epirubicin—sarcoma	0.000134	0.000567	CcSEcCtD
Boceprevir—Agitation—Doxorubicin—sarcoma	0.000134	0.000567	CcSEcCtD
Boceprevir—Anxiety—Epirubicin—sarcoma	0.000134	0.000565	CcSEcCtD
Boceprevir—CTSS—Immune System—PDGFRA—sarcoma	0.000133	0.000732	CbGpPWpGaD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000133	0.000563	CcSEcCtD
Boceprevir—Discomfort—Epirubicin—sarcoma	0.000132	0.000561	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—SRC—sarcoma	0.000132	0.000726	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—KRAS—sarcoma	0.000132	0.000726	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—KRAS—sarcoma	0.000132	0.000726	CbGpPWpGaD
Boceprevir—Malaise—Doxorubicin—sarcoma	0.000131	0.000556	CcSEcCtD
Boceprevir—Dry mouth—Epirubicin—sarcoma	0.000131	0.000555	CcSEcCtD
Boceprevir—Vertigo—Doxorubicin—sarcoma	0.000131	0.000554	CcSEcCtD
Boceprevir—Syncope—Doxorubicin—sarcoma	0.000131	0.000553	CcSEcCtD
Boceprevir—Leukopenia—Doxorubicin—sarcoma	0.00013	0.000552	CcSEcCtD
Boceprevir—Confusional state—Epirubicin—sarcoma	0.00013	0.000548	CcSEcCtD
Boceprevir—Palpitations—Doxorubicin—sarcoma	0.000129	0.000545	CcSEcCtD
Boceprevir—Loss of consciousness—Doxorubicin—sarcoma	0.000128	0.000542	CcSEcCtD
Boceprevir—Infection—Epirubicin—sarcoma	0.000128	0.00054	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—NRAS—sarcoma	0.000127	0.000699	CbGpPWpGaD
Boceprevir—Cough—Doxorubicin—sarcoma	0.000127	0.000538	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—SRC—sarcoma	0.000127	0.000697	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—KRAS—sarcoma	0.000127	0.000697	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—KRAS—sarcoma	0.000127	0.000697	CbGpPWpGaD
Boceprevir—Shock—Epirubicin—sarcoma	0.000126	0.000535	CcSEcCtD
Boceprevir—Nervous system disorder—Epirubicin—sarcoma	0.000126	0.000533	CcSEcCtD
Boceprevir—Thrombocytopenia—Epirubicin—sarcoma	0.000126	0.000533	CcSEcCtD
Boceprevir—Hypertension—Doxorubicin—sarcoma	0.000126	0.000532	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—IGF1R—sarcoma	0.000125	0.000689	CbGpPWpGaD
Boceprevir—CTSK—Immune System—KIT—sarcoma	0.000125	0.000689	CbGpPWpGaD
Boceprevir—Tachycardia—Epirubicin—sarcoma	0.000125	0.000531	CcSEcCtD
Boceprevir—Skin disorder—Epirubicin—sarcoma	0.000125	0.000528	CcSEcCtD
Boceprevir—Hyperhidrosis—Epirubicin—sarcoma	0.000124	0.000526	CcSEcCtD
Boceprevir—Myalgia—Doxorubicin—sarcoma	0.000124	0.000525	CcSEcCtD
Boceprevir—Chest pain—Doxorubicin—sarcoma	0.000124	0.000525	CcSEcCtD
Boceprevir—Arthralgia—Doxorubicin—sarcoma	0.000124	0.000525	CcSEcCtD
Boceprevir—Anxiety—Doxorubicin—sarcoma	0.000124	0.000523	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000123	0.000521	CcSEcCtD
Boceprevir—Discomfort—Doxorubicin—sarcoma	0.000122	0.000519	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—NRAS—sarcoma	0.000122	0.000671	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—JUN—sarcoma	0.000121	0.000667	CbGpPWpGaD
Boceprevir—Dry mouth—Doxorubicin—sarcoma	0.000121	0.000513	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—CTNNB1—sarcoma	0.00012	0.000662	CbGpPWpGaD
Boceprevir—Hypotension—Epirubicin—sarcoma	0.00012	0.000508	CcSEcCtD
Boceprevir—Confusional state—Doxorubicin—sarcoma	0.00012	0.000507	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—FOXO1—sarcoma	0.000119	0.000656	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CREB1—sarcoma	0.000119	0.000656	CbGpPWpGaD
Boceprevir—CTSV—Immune System—MDM2—sarcoma	0.000119	0.000655	CbGpPWpGaD
Boceprevir—CTSL—Immune System—MDM2—sarcoma	0.000119	0.000655	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PDGFRB—sarcoma	0.000119	0.000655	CbGpPWpGaD
Boceprevir—Infection—Doxorubicin—sarcoma	0.000118	0.0005	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—PDGFRA—sarcoma	0.000117	0.000644	CbGpPWpGaD
Boceprevir—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000117	0.000496	CcSEcCtD
Boceprevir—Shock—Doxorubicin—sarcoma	0.000117	0.000495	CcSEcCtD
Boceprevir—Nervous system disorder—Doxorubicin—sarcoma	0.000117	0.000494	CcSEcCtD
Boceprevir—Thrombocytopenia—Doxorubicin—sarcoma	0.000116	0.000493	CcSEcCtD
Boceprevir—Insomnia—Epirubicin—sarcoma	0.000116	0.000492	CcSEcCtD
Boceprevir—Tachycardia—Doxorubicin—sarcoma	0.000116	0.000491	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—EGFR—sarcoma	0.000116	0.000637	CbGpPWpGaD
Boceprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	0.000116	0.000635	CbGpPWpGaD
Boceprevir—Skin disorder—Doxorubicin—sarcoma	0.000115	0.000489	CcSEcCtD
Boceprevir—Paraesthesia—Epirubicin—sarcoma	0.000115	0.000488	CcSEcCtD
Boceprevir—Hyperhidrosis—Doxorubicin—sarcoma	0.000115	0.000486	CcSEcCtD
Boceprevir—Dyspnoea—Epirubicin—sarcoma	0.000115	0.000485	CcSEcCtD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—JUN—sarcoma	0.000113	0.000623	CbGpPWpGaD
Boceprevir—Dyspepsia—Epirubicin—sarcoma	0.000113	0.000479	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—HRAS—sarcoma	0.000112	0.000617	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—HRAS—sarcoma	0.000112	0.000617	CbGpPWpGaD
Boceprevir—Decreased appetite—Epirubicin—sarcoma	0.000112	0.000473	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—EGFR—sarcoma	0.000111	0.000611	CbGpPWpGaD
Boceprevir—Hypotension—Doxorubicin—sarcoma	0.000111	0.00047	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Epirubicin—sarcoma	0.000111	0.00047	CcSEcCtD
Boceprevir—Fatigue—Epirubicin—sarcoma	0.000111	0.000469	CcSEcCtD
Boceprevir—Constipation—Epirubicin—sarcoma	0.00011	0.000465	CcSEcCtD
Boceprevir—Pain—Epirubicin—sarcoma	0.00011	0.000465	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—KRAS—sarcoma	0.000109	0.000601	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—SRC—sarcoma	0.000109	0.000598	CbGpPWpGaD
Boceprevir—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000108	0.000458	CcSEcCtD
Boceprevir—CTSV—Adaptive Immune System—HRAS—sarcoma	0.000108	0.000592	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—HRAS—sarcoma	0.000108	0.000592	CbGpPWpGaD
Boceprevir—Insomnia—Doxorubicin—sarcoma	0.000107	0.000455	CcSEcCtD
Boceprevir—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	0.000107	0.000589	CbGpPWpGaD
Boceprevir—Paraesthesia—Doxorubicin—sarcoma	0.000107	0.000452	CcSEcCtD
Boceprevir—CTSV—Immune System—IL2—sarcoma	0.000107	0.000585	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL2—sarcoma	0.000107	0.000585	CbGpPWpGaD
Boceprevir—Dyspnoea—Doxorubicin—sarcoma	0.000106	0.000449	CcSEcCtD
Boceprevir—Feeling abnormal—Epirubicin—sarcoma	0.000106	0.000448	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—KRAS—sarcoma	0.000105	0.000577	CbGpPWpGaD
Boceprevir—Gastrointestinal pain—Epirubicin—sarcoma	0.000105	0.000445	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—NRAS—sarcoma	0.000105	0.000575	CbGpPWpGaD
Boceprevir—Dyspepsia—Doxorubicin—sarcoma	0.000105	0.000443	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—SRC—sarcoma	0.000105	0.000574	CbGpPWpGaD
Boceprevir—CTSV—Immune System—JUN—sarcoma	0.000104	0.000569	CbGpPWpGaD
Boceprevir—CTSL—Immune System—JUN—sarcoma	0.000104	0.000569	CbGpPWpGaD
Boceprevir—Decreased appetite—Doxorubicin—sarcoma	0.000103	0.000437	CcSEcCtD
Boceprevir—CTSS—Immune System—KIT—sarcoma	0.000103	0.000567	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CTNNB1—sarcoma	0.000103	0.000565	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CTNNB1—sarcoma	0.000103	0.000565	CbGpPWpGaD
Boceprevir—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000103	0.000434	CcSEcCtD
Boceprevir—Fatigue—Doxorubicin—sarcoma	0.000102	0.000434	CcSEcCtD
Boceprevir—Urticaria—Epirubicin—sarcoma	0.000102	0.000432	CcSEcCtD
Boceprevir—Constipation—Doxorubicin—sarcoma	0.000102	0.00043	CcSEcCtD
Boceprevir—Pain—Doxorubicin—sarcoma	0.000102	0.00043	CcSEcCtD
Boceprevir—Body temperature increased—Epirubicin—sarcoma	0.000102	0.00043	CcSEcCtD
Boceprevir—Abdominal pain—Epirubicin—sarcoma	0.000102	0.00043	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—IL2—sarcoma	0.000101	0.000554	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—NRAS—sarcoma	0.000101	0.000552	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—sarcoma	9.91e-05	0.000544	CbGpPWpGaD
Boceprevir—CTSK—Immune System—MDM2—sarcoma	9.88e-05	0.000543	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—KDR—sarcoma	9.88e-05	0.000542	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CREB1—sarcoma	9.83e-05	0.00054	CbGpPWpGaD
Boceprevir—Feeling abnormal—Doxorubicin—sarcoma	9.79e-05	0.000415	CcSEcCtD
Boceprevir—Gastrointestinal pain—Doxorubicin—sarcoma	9.72e-05	0.000411	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—EGFR—sarcoma	9.54e-05	0.000524	CbGpPWpGaD
Boceprevir—Hypersensitivity—Epirubicin—sarcoma	9.46e-05	0.000401	CcSEcCtD
Boceprevir—Urticaria—Doxorubicin—sarcoma	9.44e-05	0.0004	CcSEcCtD
Boceprevir—Body temperature increased—Doxorubicin—sarcoma	9.4e-05	0.000398	CcSEcCtD
Boceprevir—Abdominal pain—Doxorubicin—sarcoma	9.4e-05	0.000398	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—HRAS—sarcoma	9.31e-05	0.000511	CbGpPWpGaD
Boceprevir—CTSL—Immune System—SRC—sarcoma	9.29e-05	0.00051	CbGpPWpGaD
Boceprevir—CTSV—Immune System—SRC—sarcoma	9.29e-05	0.00051	CbGpPWpGaD
Boceprevir—Asthenia—Epirubicin—sarcoma	9.22e-05	0.00039	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—EGFR—sarcoma	9.17e-05	0.000503	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	9.13e-05	0.000501	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—KIT—sarcoma	9.1e-05	0.0005	CbGpPWpGaD
Boceprevir—Pruritus—Epirubicin—sarcoma	9.09e-05	0.000385	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—KRAS—sarcoma	9.02e-05	0.000495	CbGpPWpGaD
Boceprevir—CTSV—Immune System—NRAS—sarcoma	8.94e-05	0.000491	CbGpPWpGaD
Boceprevir—CTSL—Immune System—NRAS—sarcoma	8.94e-05	0.000491	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—HRAS—sarcoma	8.94e-05	0.000491	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL2—sarcoma	8.83e-05	0.000485	CbGpPWpGaD
Boceprevir—Diarrhoea—Epirubicin—sarcoma	8.79e-05	0.000372	CcSEcCtD
Boceprevir—Hypersensitivity—Doxorubicin—sarcoma	8.76e-05	0.000371	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—CREB1—sarcoma	8.66e-05	0.000476	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—KRAS—sarcoma	8.66e-05	0.000476	CbGpPWpGaD
Boceprevir—CTSK—Immune System—JUN—sarcoma	8.59e-05	0.000472	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—VEGFA—sarcoma	8.58e-05	0.000471	CbGpPWpGaD
Boceprevir—Asthenia—Doxorubicin—sarcoma	8.53e-05	0.000361	CcSEcCtD
Boceprevir—CTSK—Immune System—CTNNB1—sarcoma	8.52e-05	0.000468	CbGpPWpGaD
Boceprevir—Dizziness—Epirubicin—sarcoma	8.49e-05	0.00036	CcSEcCtD
Boceprevir—Pruritus—Doxorubicin—sarcoma	8.41e-05	0.000356	CcSEcCtD
Boceprevir—Vomiting—Epirubicin—sarcoma	8.17e-05	0.000346	CcSEcCtD
Boceprevir—CTSV—Immune System—EGFR—sarcoma	8.15e-05	0.000447	CbGpPWpGaD
Boceprevir—CTSL—Immune System—EGFR—sarcoma	8.15e-05	0.000447	CbGpPWpGaD
Boceprevir—CTSS—Immune System—MDM2—sarcoma	8.13e-05	0.000447	CbGpPWpGaD
Boceprevir—Diarrhoea—Doxorubicin—sarcoma	8.13e-05	0.000344	CcSEcCtD
Boceprevir—Rash—Epirubicin—sarcoma	8.1e-05	0.000343	CcSEcCtD
Boceprevir—Dermatitis—Epirubicin—sarcoma	8.09e-05	0.000343	CcSEcCtD
Boceprevir—Headache—Epirubicin—sarcoma	8.05e-05	0.000341	CcSEcCtD
Boceprevir—Dizziness—Doxorubicin—sarcoma	7.86e-05	0.000333	CcSEcCtD
Boceprevir—CTSK—Immune System—SRC—sarcoma	7.7e-05	0.000423	CbGpPWpGaD
Boceprevir—CTSV—Immune System—KRAS—sarcoma	7.7e-05	0.000423	CbGpPWpGaD
Boceprevir—CTSL—Immune System—KRAS—sarcoma	7.7e-05	0.000423	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—HRAS—sarcoma	7.66e-05	0.000421	CbGpPWpGaD
Boceprevir—Nausea—Epirubicin—sarcoma	7.63e-05	0.000323	CcSEcCtD
Boceprevir—Vomiting—Doxorubicin—sarcoma	7.56e-05	0.00032	CcSEcCtD
Boceprevir—Rash—Doxorubicin—sarcoma	7.49e-05	0.000317	CcSEcCtD
Boceprevir—Dermatitis—Doxorubicin—sarcoma	7.49e-05	0.000317	CcSEcCtD
Boceprevir—Headache—Doxorubicin—sarcoma	7.45e-05	0.000315	CcSEcCtD
Boceprevir—CTSK—Immune System—NRAS—sarcoma	7.41e-05	0.000407	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—HRAS—sarcoma	7.36e-05	0.000404	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL2—sarcoma	7.27e-05	0.000399	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MDM2—sarcoma	7.17e-05	0.000394	CbGpPWpGaD
Boceprevir—CTSS—Immune System—JUN—sarcoma	7.07e-05	0.000388	CbGpPWpGaD
Boceprevir—Nausea—Doxorubicin—sarcoma	7.06e-05	0.000299	CcSEcCtD
Boceprevir—CTSS—Immune System—CTNNB1—sarcoma	7.02e-05	0.000385	CbGpPWpGaD
Boceprevir—CTSK—Immune System—EGFR—sarcoma	6.75e-05	0.000371	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	6.74e-05	0.00037	CbGpPWpGaD
Boceprevir—CTSV—Immune System—HRAS—sarcoma	6.54e-05	0.000359	CbGpPWpGaD
Boceprevir—CTSL—Immune System—HRAS—sarcoma	6.54e-05	0.000359	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL2—sarcoma	6.4e-05	0.000352	CbGpPWpGaD
Boceprevir—CTSK—Immune System—KRAS—sarcoma	6.38e-05	0.00035	CbGpPWpGaD
Boceprevir—CTSS—Immune System—SRC—sarcoma	6.34e-05	0.000348	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCND1—sarcoma	6.24e-05	0.000343	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—JUN—sarcoma	6.23e-05	0.000342	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CTNNB1—sarcoma	6.18e-05	0.000339	CbGpPWpGaD
Boceprevir—CTSS—Immune System—NRAS—sarcoma	6.1e-05	0.000335	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—SRC—sarcoma	5.59e-05	0.000307	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	5.57e-05	0.000306	CbGpPWpGaD
Boceprevir—CTSS—Immune System—EGFR—sarcoma	5.56e-05	0.000305	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—VEGFA—sarcoma	5.44e-05	0.000299	CbGpPWpGaD
Boceprevir—CTSK—Immune System—HRAS—sarcoma	5.42e-05	0.000298	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NRAS—sarcoma	5.37e-05	0.000295	CbGpPWpGaD
Boceprevir—CTSS—Immune System—KRAS—sarcoma	5.25e-05	0.000288	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MYC—sarcoma	5.01e-05	0.000275	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—EGFR—sarcoma	4.9e-05	0.000269	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	4.86e-05	0.000267	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	4.85e-05	0.000266	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	4.81e-05	0.000264	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—KRAS—sarcoma	4.63e-05	0.000254	CbGpPWpGaD
Boceprevir—CTSS—Immune System—HRAS—sarcoma	4.46e-05	0.000245	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	4.35e-05	0.000239	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	4.23e-05	0.000232	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TP53—sarcoma	4.11e-05	0.000226	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—HRAS—sarcoma	3.93e-05	0.000216	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	3.89e-05	0.000214	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	3.81e-05	0.000209	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ENO2—sarcoma	3.8e-05	0.000209	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—HBA1—sarcoma	3.78e-05	0.000208	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	3.6e-05	0.000198	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PLCG1—sarcoma	3.23e-05	0.000177	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	3.2e-05	0.000176	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ENO2—sarcoma	2.87e-05	0.000158	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HBA1—sarcoma	2.85e-05	0.000157	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PLCG1—sarcoma	2.43e-05	0.000134	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ENO2—sarcoma	1.77e-05	9.71e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HBA1—sarcoma	1.76e-05	9.65e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PLCG1—sarcoma	1.5e-05	8.24e-05	CbGpPWpGaD
